-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Initiates Coverage On Coya Therapeutics with Buy Rating, Announces Price Target of $15

Benzinga·12/04/2024 12:10:55
Listen to the news
D. Boral Capital analyst Jason Kolbert initiates coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and announces Price Target of $15.